Medicare Could Cover Melphalan Regimen For 1000 Stem Cell Procedures
Executive Summary
Medicare could cover treatment for over 1,000 multiple myeloma patients receiving high-dose chemotherapy in combination with autologous stem cell transplantation, under a recommendation by the Drugs, Biologics and Therapeutics Panel of the Medicare Coverage Advisory Committee.